Søgeresultater - Heinz Gisslinger

Refine Results
  1. 1
    Current and future treatment options for polycythemia vera

    Current and future treatment options for polycythemia vera af Martin Grießhammer, Heinz Gisslinger, Ruben A. Mesa

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Erythropoietin Treatment of Anemia Associated with Multiple Myeloma

    Erythropoietin Treatment of Anemia Associated with Multiple Myeloma af Heinz Ludwig, E. Fritz, H. Kotzmann, P Höcker, Heinz Gisslinger, Ursula Barnas

    Udgivet 1990
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

    Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification af Jürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, Veronika Buxhofer‐Ausch, Bettina Gisslinger, Heinz Gisslinger

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

    Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera af Raffaele Landolfi, Roberto Marchioli, Jack Kutti, Heinz Gisslinger, Gianni Tognoni, Carlo Patrono, Tiziano Barbui

    Udgivet 2004
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Anagrelide for thrombocytosis in myeloproliferative disorders

    Anagrelide for thrombocytosis in myeloproliferative disorders af Michael Steurer, Guenther Gastl, Wieslaw‐Wiktor Jedrzejczak, Robert Pytlík, Werner Lin, Ernst Schlögl, Heinz Gisslinger

    Udgivet 2004
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha

    Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha af Heinz Gisslinger, Bettina Gilly, W. Woloszczuk, Wolfgang R. Mayr, L Havelec, Werner Linkesch, M Weissel

    Udgivet 1992
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment

    Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment af Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Róbert Královics, Jean‐Jacques Kiladjian, Heinz Gisslinger, Jean‐Jacques Kiladjian

    Udgivet 2023
    Få fuldtekst Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  8. 8
    Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

    Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial af Heinz Gisslinger, Mirjana Gotić, Jerzy Hołowiecki, Miroslav Penka, Jüergen Thiele, Hans Michael Kvasnicka, Róbert Královics, Petro E. Petrides

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

    The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion af Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M. Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  10. 10
    Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans

    Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans af Aleksandra E. Kornienko, Christoph Dotter, Philipp Guenzl, Heinz Gisslinger, Bettina Gisslinger, Ciara Cleary, Róbert Královics, Florian M. Pauler, Denise P. Barlow

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia

    Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia af Marco Ruggeri, Heinz Gisslinger, Alberto Tosetto, C. Rintelen, Christine Mannhalter, Ingrid Pabinger, Navide Heis, Giancarlo Castaman, Edoardo Missiaglia, Klaus Lechner, Francesco Rodeghiero

    Udgivet 2002
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  12. 12
    Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F

    Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F af Franz X. Schaub, Roland Jäger, Renate Looser, Hui Hao-Shen, Sylvie Hermouet, François Girodon, André Tichelli, Heinz Gisslinger, Róbert Královics, Radek C. Skoda

    Udgivet 2008
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  13. 13
    Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

    Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma af H. Ludwig, Zdeněk Adam, E Tóthová, Roman Hájek, Boris Labar, Miklós Egyed, Ivan Špıčka, Heinz Gisslinger, Johannes Drach, Ingrid Kühn, Axel Hinke, N. Zojer

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders

    Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders af Daniela Pietra, Sai Li, Angela Brisci, Francesco Passamonti, Elisa Rumi, Alexandre Theocharides, Maurizio Ferrari, Heinz Gisslinger, Róbert Královics, Laura Cremonesi, Radek C. Skoda, Mario Cazzola

    Udgivet 2007
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma

    Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma af Heinz Ludwig, Roman Hájek, Elena Tóthová, Johannes Drach, Zdeněk Adam, Boris Labar, Miklós Egyed, Ivan Špıčka, Heinz Gisslinger, Richard Greil, Ingrid Kühn, Niklas Zojer, Axel Hinke

    Udgivet 2008
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study

    Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study af Markus S. Anker, Maria Klara Frey, Georg Goliasch, Philipp E. Bartko, Suriya Prausmüller, Heinz Gisslinger, Gabriela Kornek, Guido Strunk, Markus Raderer, Christoph Zielinski, Martin Hülsmann, Noémi Pávó

    Udgivet 2020
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study

    Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study af Heinz Ludwig, Zdeněk Adam, Roman Hájek, Richard Greil, Elena Tóthová, Felix Keil, Eva Maria Autzinger, Josef Thaler, Heinz Gisslinger, Alois Lang, Miklós Egyed, Irene Womastek, Niklas Zojer

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

    EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis af Alessandro M. Vannucchi, Peter te Boekhorst, Claire Harrison, Guangsheng He, Marianna Caramella, Dietger Niederwieser, Françoise Boyer‐Perrard, Minghui Duan, Nathalie Francillard, Betty Molloy, Monika Wroclawska, Heinz Gisslinger

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

    Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b af Jean‐Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Róbert Královics, Heinz Gisslinger, Jean‐Jacques Kiladjian, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Heinz Gisslinger

    Udgivet 2022
    Få fuldtekst Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  20. 20
    Masked polycythemia vera diagnosed according to WHO and BCSH classification

    Masked polycythemia vera diagnosed according to WHO and BCSH classification af Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Heinz Gisslinger, Guido Finazzi, Elisa Rumi, Maria Luigia Randi, Alessandro M. Vannucchi, Bettina Gisslinger, Leonhard Müllauer, Marco Ruggeri, Alessandro Rambaldi, Ayalew Tefferi

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: